| Date | Time | Source | Headline | Symbol | Company |
| 09/09/2024 | 1:34PM | iHub Newswire | FeaturedElement79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. | | |
| 09/08/2024 | 1:47PM | PR Newswire (US) | RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show strong favorable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer | NYSE:JNJ | Johnson and Johnson |
| 09/05/2024 | 4:30PM | Business Wire | Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results | NYSE:JNJ | Johnson and Johnson |
| 09/05/2024 | 6:11AM | IH Market News | Qualcomm Develops Mixed Reality Glasses; Verizon to Boost Dividend, Eyes Acquisition; Samsonite Plans US Dual Listing | NYSE:JNJ | Johnson and Johnson |
| 09/03/2024 | 4:48PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/30/2024 | 3:51PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:JNJ | Johnson and Johnson |
| 08/29/2024 | 2:05PM | Edgar (US Regulatory) | Form N-PX - Annual Report of proxy voting record of management investment companies | NYSE:JNJ | Johnson and Johnson |
| 08/29/2024 | 8:00AM | PR Newswire (US) | Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis | NYSE:JNJ | Johnson and Johnson |
| 08/27/2024 | 8:00AM | PR Newswire (US) | Johnson & Johnson is transforming solid tumor cancer outcomes with new data at the 2024 World Conference on Lung Cancer and European Society for Medical Oncology Congress | NYSE:JNJ | Johnson and Johnson |
| 08/26/2024 | 4:26PM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 08/26/2024 | 8:58AM | IH Market News | IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts | NYSE:JNJ | Johnson and Johnson |
| 08/26/2024 | 8:00AM | Business Wire | Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024 | NYSE:JNJ | Johnson and Johnson |
| 08/21/2024 | 8:12AM | IH Market News | Walmart Sells JD.com Stake, Microchip Suffers Cyberattack, Union Pacific Warns of Strike in Canada, and Latest News | NYSE:JNJ | Johnson and Johnson |
| 08/20/2024 | 7:30AM | Business Wire | Johnson & Johnson to Acquire V-Wave | NYSE:JNJ | Johnson and Johnson |
| 08/20/2024 | 7:00AM | PR Newswire (US) | RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) approved in the U.S. as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer | NYSE:JNJ | Johnson and Johnson |
| 08/15/2024 | 6:05AM | IH Market News | Google Mandated to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys Kellanova | NYSE:JNJ | Johnson and Johnson |
| 08/15/2024 | 6:05AM | IH Market News | Google Forced to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys Kellanova | NYSE:JNJ | Johnson and Johnson |
| 08/13/2024 | 5:43AM | IH Market News | Dell Stock Slide Offers Opportunities; Trump and Musk hold talks on X; GM Restructures China Operations, and More | NYSE:JNJ | Johnson and Johnson |
| 08/09/2024 | 4:35PM | Edgar (US Regulatory) | Form 13F-HR - Quarterly report filed by institutional managers, Holdings | NYSE:JNJ | Johnson and Johnson |
| 08/07/2024 | 5:00PM | PR Newswire (US) | Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of Medicine | NYSE:JNJ | Johnson and Johnson |
| 07/30/2024 | 9:06PM | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NYSE:JNJ | Johnson and Johnson |
| 07/30/2024 | 6:42PM | PR Newswire (US) | DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant-eligible | NYSE:JNJ | Johnson and Johnson |
| 07/30/2024 | 6:00AM | IH Market News | Toyota Reports Another Global Production Decline, Delta Sues CrowdStrike, Meta Launches AI Studio for Custom Chatbots | NYSE:JNJ | Johnson and Johnson |
| 07/29/2024 | 4:00PM | Business Wire | Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
| 07/26/2024 | 9:38AM | Business Wire | Courts, Congress Likely to Stand in Way of J&J’s Third Texas Two-Step Plan | NYSE:JNJ | Johnson and Johnson |
| 07/26/2024 | 9:05AM | Business Wire | FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan | NYSE:JNJ | Johnson and Johnson |
| 07/26/2024 | 6:07AM | IH Market News | Alphabet Unveils AlphaProof and AlphaGeometry 2; OpenAI Tests SearchGPT; Apple Loses Market Share in China | NYSE:JNJ | Johnson and Johnson |
| 07/25/2024 | 4:02PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:JNJ | Johnson and Johnson |
| 07/23/2024 | 4:00PM | Business Wire | Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
| 07/22/2024 | 11:59AM | Business Wire | Lawyers for Ovarian Cancer Victims Urge NO Vote on J&J’s Latest Bankruptcy Plan | NYSE:JNJ | Johnson and Johnson |